32名の方が先月見積もりをリクエストしました
Mustafa Solak
- 2 良い • 2 レビュー
- 20年の経験
- 所在地: トルコ, イスタンブール
ソラク医師はアンドロゲン除去療法を専門とし、ヒサール・ホスピタル・インターコンチネンタルにて複雑な症例の治療を行っています。
- ハジェテペ大学がん研究所にてフェローシップを修了
- 乳がん、精巣がん、および卵巣がんの専門家
- テキサス大学MDアンダーソンがんセンターにて研修を受講
- 続きを読む
トルコのトップアンドロゲン遮断療法医師と価格を比較。こちらで最適なマッチングを見つけてください
ご要望と予算に基づいて最適な医師を厳選いたします
医学的監修者 Fahad Mawlood
医学編集者・データサイエンティストトップ医師
7
トルコ
レビュー
14000+
実際の患者より
トップ各国のアンドロゲン遮断療法価格を比較
国をタップしてトップ医師と価格を表示
個別化された治療計画を無料で取得し、最良のオプションを選択してください。コミットメント不要 · サービス料金なし
最初に表示:
32名の方が先月見積もりをリクエストしました
ソラク医師はアンドロゲン除去療法を専門とし、ヒサール・ホスピタル・インターコンチネンタルにて複雑な症例の治療を行っています。
55名の方が先月見積もりをリクエストしました
エダ・タンルクリ博士はアナドル・メディカルセンターにおけるがんのトップ腫瘍専門医の一人で、医学的腫瘍学と化学療法に専門知識を持っています。
教育
2005年にアンカラ大学医学部を卒業後、彼女は2006年にカルスで必修サービスを完了しました。2007年から2012年にかけてイスタンブール大学ジェッラパシャ医学部で内科の専門研修を完了しました。彼女は2013年にトルコで実施された小専門医試験で3位になり、マルマラ大学医学部の医学腫瘍学科で医学腫瘍学の研修を開始しました。2017年に医学腫瘍の専門研修を完了し、2018年から2021年までハイダルパシャ ヌミュ内科および腫瘍ユニットの責任者として勤務しました。医学腫瘍の分野で多くの国際臨床研究で助手および主任研究者として勤務したタンルクリ・シムシェクは、2021年12月からアナドル・メディカルセンターで医学腫瘍医として勤務を開始しました。
専門
16名の方が先月見積もりをリクエストしました
イルケル・ティナイ医師は、アナドール医療センターで、低侵襲手術、ネオ膀胱再建手術、泌尿器がんのエキスパートである泌尿器科腫瘍専門医です。彼は英語とドイツ語を話し、イスタンブール大学で学士号を取得し、マルマラ大学で泌尿器科のレジデンシーを完了しました。
Urooncology協会科学研究賞、2019年
Urooncology協会理事会 メンバー
機関会員
Urooncology協会膀胱腫瘍研究グループ 書記
Prof. Dr. Önder SÜRGİT is a General Surgeon in the General Surgery Clinic. Working hours: 09:00–18:00. Core practice areas include laparoscopic surgery, cancer surgery, and bariatric surgery.
Graduated from Hacettepe Faculty of Medicine in 1995. Academic title: Professor. Served as Instructor Surgeon at ITEM (Advanced Medical Technologies Training Center). Held faculty roles at Turgut Özal University and Atılım University, Faculties of Medicine. Also worked at Ankara Medicana Hospital and Optimed Health Group. Foreign language: English.
Experience
2022 PRIVATE MEDIPOL BAHÇELİEVLER HOSPITAL
2021 - 2021 Prof. Dr. Cemil Taşçıoğlu City Hospital, Medical Oncology Clinic Education Officer
2021 - 2021 Prof. Dr. Cemil Taşçıoğlu City Hospital
2020 - 2021 Yüzüncü Yıl University Faculty of Medicine
2020 - 2021 Head of the Department of Medical Oncology, Yüzüncü Yıl University Faculty of Medicine, Assoc. Dr.
2018 - 2021 Lecturer - Yüzüncü Yıl University Faculty of Medicine, Head of Medical Oncology Department
2018 - 2021 Yüzüncü Yıl University Faculty of Medicine
2015 - 2018 University of Health Sciences, Okmeydanı Training and Research Hospital
2015 - 2018 University of Health Sciences, Okmeydanı Training and Research Hospital, Medical Oncology Clinic, Sub-branch assistant
2012 - 2015 Kanuni Sultan Süleyman Training and Research Hospital, Internal Medicine specialist
2012 - 2015 Suleiman the Magnificent Training and Research Hospital,
2008 - 2012 Haseki Training and Research Hospital
2006 - 2008 Kızıltepe No. 3 Health Center General Practitioner.
Education
2018
İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji
2018
İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji, İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji
2012
İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları, İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları
2012
İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları
2007
Uludağ Üniversitesi Tıip Fakültesi, Tıip Fakültesi, Uludağ Üniversitesi Tıip Fakültesi, Tıip Fakültesi
プロフェッサー ネジデット・ユシュケントは、アンカラ大学医学部を卒業しました。彼はアンカラGATA医学校で内科医学のレジデンシー研修を修了しました。彼はアメリカのテキサス州ダラスで医療用腫瘍学および血液学の臨床フェローシップ研修を行いました。トルコで最初の移植を実施した骨髄移植チームに参加しました。異なる時期に、彼はロンドンのウェストミンスター病院 チャリングクロス、ハマースミス、ロイヤル フリー、ユニバーシティ カレッジ 病院で長期間の客員講師を務め、スイスのバーゼル カントン病院でも講義しました。欧州医学腫瘍学会(ESMO)によって主催された試験に合格し、彼はヨーロッパ医学腫瘍学証明書を取得しました。トルコ医学腫瘍学会の7人の創設会員の1人として、プロフェッサー ユシュケントはトルコ腫瘍学グループ(TOG)の創設者でもありました。
学歴
アンカラ大学医学部, アンカラ 1971
GATA 医学校, アンカラ 1979
ワドレー分子医学研究所, グランビル・モートンがん病院, 医療用腫瘍学および血液学のサブスペシャリティ, 1982
GATA 医学校, 医療用腫瘍学クリニック, アンカラ 1984
GATA 医学校, 医療用腫瘍学クリニック, アンカラ 1989
GATA, 医療用腫瘍学および血液学クリニック, イスタンブール 2001
専門分野
海外のクリニックを選ぶことはストレスフルです。800,000名以上の患者をサポートしたBookimedは、お客様の懸念を理解しています。信頼できる医師、最高の価格品質オプション、複雑なケースの解決策を見つける方法を知っています。すべての段階でお客様をご案内いたします。
ヤン・マツィイフスキー
医療コーディネーターチーム責任者
4300+件以上の患者の旅をガイド
Bookimedで3年
Turkeyの278名の患者が今月当社を通じて医師を見つけました
2分のクイズ
目標、予算、スケジュールをお聞かせください
人間のマッチング + AI
アルゴリズムがマッチングを見つけ、コーディネーターが適合性を確認します
オプション準備完了
価格、パッケージ、日程を比較。コーディネーターとチャット
選択肢に迷っていますか?
治療をガイド
医療訓練を受けた専属コーディネーター






| 順位 | 医師 | 経験 | 適合する方 | 特色 | クリニックと所在地 | 診察 |
|---|---|---|---|---|---|---|
| #1 | 20年の経験 | 複雑ながん症例 | アンダーソンがんセンターでの研修を経て、アンドロゲン除去療法を専門とする。乳がんおよび精巣がんを含む複数のがん種に精通した専門家。 | トルコ | から $100 |
Androgen deprivation therapy in Turkey involves a multidisciplinary team including urologists, medical oncologists, and radiation oncologists. These specialists work together to manage advanced prostate cancer through hormone suppression. Expert physicians prescribe medications and track hormonal response to ensure treatment efficacy.
Bookimed Expert Insight: Leading Turkish oncologists often have extensive international training at top institutions like MD Anderson Cancer Center. Bookimed data shows that doctors like Dr. Mustafa Solak and Prof. Dr. Necdet Üskent offer consultations starting from $100 to $215. This high level of specialization ensures that complex hormone-sensitive cases receive care based on global protocols.
Patient Consensus: Patients note that urologists typically start the treatment right after a diagnosis. Many find they need to clarify which specialist will handle the long-term PSA blood tests. Those who choose private hospitals appreciate the organized follow-up schedules for monitoring hormone levels.
Turkey hosts internationally recognized oncologists specializing in androgen deprivation therapy at JCI-accredited centers. These experts often hold fellowships from prestigious institutions like MD Anderson. They provide advanced hormone management within multidisciplinary teams. This approach effectively controls prostate cancer progression for international patients.
Bookimed Expert Insight: Data shows a strong trend of Turkish oncologists pursuing highly specialized clinical fellowships abroad. For instance, Dr. Mustafa Solak specifically focused on oncology at Hacettepe University. This intensive specialization ensures patients receive hormone protocols that align with current global standards.
Patient Consensus: Patients often mention feeling relieved by the clear communication regarding their hormone treatment plans. Many note the high level of coordination between different specialists during their hospital stay. They appreciate the detailed explanations about how the therapy affects their specific condition.
Turkish androgen deprivation therapy specialists frequently collaborate with international medical centers through formal institutional partnerships and research training. Leading clinics like Anadolu Medical Center maintain solid ties with Johns Hopkins Medicine Institute. This allows local specialists to follow global protocols for prostate cancer management.
Bookimed Expert Insight: Data shows that collaboration in Turkey often follows a specialized training pattern. Many top oncologists are not just members of international groups like ESMO but have held clinical roles at premier US and UK centers. For instance, Dr. Mustafa Solak and Dr. Necdet Uskent both bring direct experience from top-tier Texas cancer facilities to their private practices in Istanbul.
Patient Consensus: Patients note that collaboration often works through sharing translated reports and digital medical records. They suggest bringing your complete PSA history to ensure smooth communication between doctors. Most find that coordinators at larger hospitals handle document exchange efficiently for follow-up care.
Turkish androgen deprivation therapy specialists hold mandatory national board certifications in urology or medical oncology. Many secure prestigious international credentials from the European Society for Medical Oncology. These experts often complete advanced fellowships at top-tier institutions like MD Anderson Cancer Center in the USA.
Bookimed Expert Insight: Data shows that premier Turkish specialists often hold academic professorships while maintaining active international memberships. For example, Dr. Mustafa Solak and Prof. Necdet Uskent were among the seven founding members of the Turkish Society of Medical Oncology. This level of institutional leadership suggests they stay ahead of evolving hormonal therapy protocols and research trends.
Patient Consensus: Patients value doctors who have been trained at reputable Turkish universities and hold active medical chamber registrations. They notice a difference when a specialist personally manages their laboratory follow-ups for PSA and testosterone levels. Seeing a professor with many published research papers provides a strong sense of trust during complex cancer treatments.
Patients undergoing androgen deprivation therapy in Turkey typically see their doctor every 3 to 6 months. This schedule matches standard depot injection cycles. Specialists conduct an initial checkup approximately one month after starting. They monitor hormone levels and managing side effects during these routine visits.
Bookimed Expert Insight: Data shows many leading Turkish oncologists, such as Dr. Mustafa Solak at Hisar Hospital Intercontinental, bring international experience from institutions like MD Anderson. This global training often leads to flexible follow-up models. Patients can frequently coordinate local blood tests and schedule professional reviews around their travel plans. Online consultations are also widely available, with fees starting from $100 for some specialists.
Patient Consensus: Patients note that visits often align with their injection schedule, making the process quite manageable. Many were relieved to find they could use local labs between trips for routine blood work. They emphasize that while hot flashes and fatigue are common, doctors are very helpful with management.
Turkish specialists choose between medical and surgical androgen deprivation therapy based on clinical urgency and patient health history. Leading oncologists like Dr. Mustafa Solak and Dr. Eda Tanrikulu prioritize medical ADT for its reversibility. Urologists often select surgery for patients requiring rapid testosterone reduction to prevent bone pain or spinal compression.
Bookimed Expert Insight: Data shows that many top Turkish specialists have international training. Dr. Mustafa Solak trained at MD Anderson and Prof. Necdet Uskent at University College London. This global exposure means they apply international protocols, often using expensive GnRH antagonists to avoid flares before resorting to surgery.
Patient Consensus: Patients note that medical therapy feels less permanent and offers more psychological comfort. Many choose surgery as a practical step to avoid the stress of recurring injections and pharmacy supplies. They suggest discussing long-term goals early since the emotional impact on identity is similar for both options.